Cargando…

Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn's disease

BACKGROUND/AIMS: The use of anti-tumor necrosis factor (anti-TNF) agents seems to reduce surgical rates and delay surgical procedures in prospective trials and population-based studies in the management of Crohn's disease (CD). This study aimed to identify whether preoperative anti-TNF agents i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotze, Paulo Gustavo, Magro, Daniela Oliveira, Saab, Barbara, Saab, Mansur Paulo, Pinheiro, Lilian Vital, Olandoski, Marcia, Ayrizono, Maria de Lourdes Setsuko, Martinez, Carlos Augusto Real, Coy, Claudio Saddy Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797273/ https://www.ncbi.nlm.nih.gov/pubmed/29422799 http://dx.doi.org/10.5217/ir.2018.16.1.62

Ejemplares similares

Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease
por: Magro, Daniéla Oliveira, et al.
Publicado: (2017)

Adenocarcinoma of the Right Colon in a Patient with Bloom Syndrome
por: Martinez, Carlos Augusto Real, et al.
Publicado: (2016)

Long Time from Diagnosis to Surgery May Increase Postoperative Complication Rates in Elective CD Intestinal Resections: An Observational Study
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Multiple desmoid tumors in a patient with Gardner's syndrome – Report of a case
por: Pinheiro, Lílian Vital, et al.
Publicado: (2014)

Mucinous adenocarcinoma associated with chronic suppurative hidradenitis: Report of a case and review of the literature
por: Mukai, Natalia, et al.
Publicado: (2016)

Defective Apoptosis in Intestinal and Mesenteric Adipose Tissue of Crohn’s Disease Patients
por: Dias, Cilene Bicca, et al.
Publicado: (2014)

Remission in Crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
por: Magro, Daniéla Oliveira, et al.
Publicado: (2019)

Intramucosal Carcinoma of the Appendix Arising from Traditional Serrated Adenoma
por: Martinez, Carlos Augusto Real, et al.
Publicado: (2015)

Paraestomal hernia with gastric outlet obstruction: a case report and literature review
por: de Andrade, Vitor Augusto, et al.
Publicado: (2018)

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
por: Kotze, Paulo Gustavo, et al.
Publicado: (2017)

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Teixeira, Fabio Vieira, et al.
Publicado: (2019)

Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn’s disease: a narrative review
por: Miranda, Eron Fabio, et al.
Publicado: (2021)

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study
por: de Souza, Letícia Rodrigues, et al.
Publicado: (2023)

Ileal pouch of ulcerative colitis and familial adenomatous polyposis patients exhibit modulation of autophagy markers
por: Paiva, Nielce Maria, et al.
Publicado: (2018)

Mucinous adenocarcinoma in perianal fistula in Crohn's disease: Case report and literature review
por: de Souza, Ana Beatriz Pereira, et al.
Publicado: (2022)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
por: Pichler, Judith, et al.
Publicado: (2020)

Biologics and surgical outcomes in Crohn’s disease: is there a direct relationship?
por: Quaresma, Abel Botelho, et al.
Publicado: (2020)

Mesenchymal Stem Cells for Perianal Crohn’s Disease
por: Carvello, Michele, et al.
Publicado: (2019)

Dietary Patterns Associated to Clinical Aspects in Crohn’s Disease Patients
por: de Castro, Marina Moreira, et al.
Publicado: (2020)

Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
por: Imbrizi, Marcello, et al.
Publicado: (2023)

C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma
por: Credidio, Laura, et al.
Publicado: (2014)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Endoscopic Postoperative Recurrence Rates in Crohn's Disease in Korea: The Beginning of a New Approach?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2014)

Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease
por: Sakatani, Aki, et al.
Publicado: (2013)

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements
por: Walden, Daniel, et al.
Publicado: (2022)

The old versus the new: which do you keep in postoperative Crohn's disease?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study
por: Kotze, Paulo Gustavo, et al.
Publicado: (2015)

Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients
por: Coope, Andressa, et al.
Publicado: (2017)

ER stress activation in the intestinal mucosa but not in mesenteric adipose tissue is associated with inflammation in Crohn’s disease patients
por: Coope, Andressa, et al.
Publicado: (2019)

Feasibility of endoscopic submucosal dissection for gastric and colorectal lesions: Initial experience from the Gastrocentro – Unicamp
por: Meirelles Santos, Jose Olympio, et al.
Publicado: (2013)

Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy Results
por: Viana Freitas, Bianca Rosa, et al.
Publicado: (2013)

Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis
por: Planell, Núria, et al.
Publicado: (2017)

Ferric carboxymaltose for anemia in Crohn’s disease patients at a tertiary center: A retrospective observational cohort study
por: Siqueira, Natália Souza Nunes, et al.
Publicado: (2023)

Sickle cell disease: from the beginning until it was recognized as a public health disease
por: Naoum, Paulo Cesar
Publicado: (2011)

TISSUE EXPRESION OF THE GENES MUTYH AND OGG1 IN PATIENTS WITH SPORADIC COLORECTAL CANCER
por: NASCIMENTO, Enzo Fabrício Ribeiro, et al.
Publicado: (2017)

Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn’s disease
por: da Silva, Francesca Aparecida Ramos, et al.
Publicado: (2020)

Late preterm infants’ motor development until term age
por: Santos, Viviane Martins, et al.
Publicado: (2017)

Acceptability of an Alimentary Supplement of Whey-Protein Concentrate and TGF-β in Patients with Crohn's Disease
por: Davanço, Taciana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_itu1r34n377rde1ooito57bgc6